Table 1.

Baseline characteristics of patients with T2D according to outcome during 8–12 years of follow-up

Baseline CharacteristicOutcomeP Value
Alive (n=267)ESRD (n=59)Deceased (n=84)Alive Compared with ESRDAlive Compared
with DeceasedESRD Compared with Deceased
Male54.747.565.61.000.890.35
Age (yr)54±1059±860±70.003<10−51.00
Body mass index (kg/m2)29.7±5.931.5±7.129.4±6.51.001.001.00
Systolic BP (mmHg)134±17143±20134±180.0131.000.21
Serum cholesterol (mg/dl)a229±49241±56227±451.001.001.00
Duration of diabetes (yr)12±817±716±810−410−31.00
HbA1c8.3±1.78.9±1.68.6±1.60.651.001.00
AER (μg/min)20 (12, 66)623 (321, 1579)72 (22, 217)<10−30<10−7<10−30
eGFR (ml/min per 1.73 m2)100±2761±3190±30<10−300.09<10−6
Treated with insulin51.586.473.8<10−40.0040.75
Treated with RASi/AHTN45.164.350.70.111.001.00
  • Data are mean ± SD, median (25th, 75th percentiles), or percentage. The 3×2 chi-squared or ANOVA test was used. Bonferroni correction for the number of clinical variables (n=11). RASi/AHTN, renin-angiotensin system inhibitors and/or other antihypertensive agent.

  • a To convert values for cholesterol to millimoles per liter, multiply by 0.02586.